CS

Chromisa Scientific

BE0754.910.220

2025
2024
2022
2021
Gross margin
€ -10K
€ -46K
€ 77K
€ 56K
Profit
€ -26K
€ -63K
€ 47K
€ 31K
Equity
€ 18K
€ 44K
€ 86K
€ 40K
Credit limit
€ 628
€ 2K
€ 87K
€ 55K
Taxes
€ 1K
€ 14K
€ 9K
Salaries and Social Security Contributions
Dividends
€ 800
€ 800
Dividend payout
1.71%
2.56%
EBITDA
€ -10K
€ -46K
€ 77K
€ 56K
EBIT
€ -20K
€ -57K
€ 67K
€ 45K
Net profit
€ -26K
€ -63K
€ 47K
€ 31K
Capex
-
-
€ 4K
Cash
€ 37K
€ 60K
€ 104K
€ 60K
Cashflow
€ -16K
€ -52K
€ 57K
€ 42K
Working capital
€ 15K
€ 31K
€ 65K
€ 26K
Current ratio
1.18
1.33
1.85
1.59
Quick ratio
1.34
1.51
1.85
1.59
Working capital ratio
1.25
1.41
1.85
1.59
Assets
€ 101K
€ 138K
€ 176K
€ 111K
Debt
€ 83K
€ 94K
€ 89K
€ 70K
Short-term debt
€ 78K
€ 88K
€ 77K
€ 45K
Long-term debt
€ 12K
€ 25K
Solvability
17.72%
31.85%
49.22%
36.61%
Long term debt ratio
0.14
0.62
Debt / EBITDA
1.16
1.25
Interest Coverage Ratio
Gross profitability
-91.79%
-119.43%
65.83%
104.09%
Net profitability
-145.92%
-143.57%
54.08%
77.28%
Return On Assets (ROA)
-25.86
-45.73
26.62
28.29
Return On Equity (ROE)
-145.92
-143.57
54.08
77.28
Customer credit
Supplier credit
Days Sales Outstanding (DSO)
Days Sales of Inventory (DSI)
Inventory Turnover Ratio
Employees
Staff cost per employee